Scouring sources for information on GLP1 Agonist drugs, so you don't have to.
Keeping track of negative side effects of GLP1s is just as important (if not more important) than keeping track of positive side effects. Cyclic Vomiting Syndrome is a *rare* negative side effect that doesn’t come up in the research very often, but after hearing anecdotal reports of this side
Here’s what happened last week in the GLP1 ecosystem: 🌎 World Health Organization (WHO) adds GLP1 to essential medicines list (for diabetes) 🏛️ FDA Creates 'Green List' of GLP-1 Drug Ingredients Approved for Entry in the U.S. 🧑⚖️ CVS Caremark gets sued for stopping coverage of GLP1s 📰 GLP-1 Receptor
Here’s what happened last week in the GLP1 ecosystem: 📑 Orforglipron Phase 3 trial results landed 📢 TEVA Pharmaceuticals announced FDA approval for weight loss with Liraglutide 🎤 Meghan Trainor has been in the news after a GLP1 transformation 🎾 Serena Williams has shared her GLP1 story Go deeper, read more Here are
drug:orforglipron
We take a look at the most recent set of results from Orforglipron, the oral GLP1 from Eli Lilly
drug:cagrisema
We take a look at the recent results for CagriSema, and see how it tracks against other GLP1s
chemical:semaglutide
Recent reports of kidney injuries have caused a change in requirements for GLP1 labeling. We dive into the actual risk and what you can do about it.
drug:mounjaro
Trulicity and Mounjaro go head to head, in a clinical trial that finally puts to bed the question of which is better.
politics
GLP1s might be covered under Medicare/medicaid again. The Trump administration introduces a new experiment under the CMMI.
drug:phentermine
Reports of combining GLP1s with Phentermine suggest superior results. What is Phentermine and how can it be used with GLP1s?
chemical:semaglutide
Yet another manufacturer signs up to produce generic Semaglutide for much of the world (ex. EU and USA) - what does Dr. Reddy's have planned?
company:hims
Hims is going to start selling generic Semaglutide in 2026, long before US patents expire. How?
company:novo-nordisk
Novo Nordisk is looking to introduce a new higher dosage of Semaglutide (Wegovy) -- we take a look at the studies they *didn't* submit.